drugset / Trial / NCT00044135
A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of the study is to evaluate the safety and effectiveness of 12 weeks of treatment with clevudine, at one of three doses, in patients chronically infected with hepatitis B virus.
Timeline
- Start
- 2002-08
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clevudine | Small molecule | 10 mg | — |
| Subject | Clevudine | Small molecule | 30 mg | — |
| Subject | Clevudine | Small molecule | 50 mg | — |